In my research, I am interested in clinical trials that use an adaptive design. An adaptive design allows researchers to look at the information collected during a trial, rather than waiting until the ...
The partnership will integrate PhaseV's adaptive clinical trial technology with Alimentiv's comprehensive GI CRO services.
Gastrointestinal-focused CRO Alimentiv is upgrading its clinical trials with software firm PhaseV’s adaptive trial technology ...
When undertaking a clinical trial an adaptive design (AD) has the potential to offer efficiency in addressing study research objectives, as well as ethical advantages by minimising the number of ...
In early phase trials innovative designs offer potential for improvements in efficiency and decision-making. Determining the ...
Angus, Derek C., Brian M. Alexander, Scott Berry, Meredith Buxton, Roger Lewis, Melissa Paoloni, Steven A. R. Webb, Steven Arnold, Anna Barker, Donald A. Berry, Marc ...
academics and companies is being heralded as a milestone in clinical trials. The I-SPY 2 TRIAL, which involves 20 US cancer centers, will follow an adaptive trial design that promises both time ...
Newronika announced today that it received FDA investigational device exemption (IDE) for its deep brain stimulation (DBS) system.
In this video interview, Michael Andreini, president and CEO of the Multiple Myeloma Research Foundation, highlights the ...
PhaseV has formed a strategic collaboration with Alimentiv to support the design and execution of adaptive clinical trials targeting gastrointestinal (GI) conditions. This collaboration ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results